CDSCO invites public comments on Draft Guidelines for Good Clinical Practices till 12th October 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Central Drugs Standard Control Organization (“CDSCO”) has invited comments/suggestions on... Read More
NPPA revises ceiling price of Chloroquine (150mg) tablet price to Rs. 1.33 per tablet; manufacturers directed to align pricing with ceiling price by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe National Pharmaceutical Pricing Authority (“NPPA”), after reviewing the Wholesale... Read More
Centre notifies Uniform Code for Marketing Practices in Medical Devices 2024; mandates annual self-declarations on Code adherence and disclosure of expenses on medical education/conferences and free samples through UCPMP portal by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has notified the Uniform Code for Marketing Practices in Medical... Read More
Pharmaceutical companies mandated to disclose free sample and continuing medical education /conference related expenses on UCPMP portal within two months of financial year-end by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has directed pharmaceutical companies to submit a declaration... Read More
Health Ministry prohibits the manufacture, sale or distribution of 156 Fixed Dose Combinations by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Health and Family Welfare (MoHFW) has implemented an immediate ban on 156... Read More